Associate Kathryn Kayali recently served as a panelist at the 9th Annual Supreme Court Intellectual Property Review, hosted by Chicago-Kent College of Law, where she discussed the upcoming Supreme Court case Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, No 17-1229, in which Williams & Connolly represents Petitioner.
The presentation covered the reasons law firms designate in-house counsel, the role of such counsel, and scenarios commonly confronted by such counsel, including steps to take when a client or former client may assert a malpractice claim.
The speakers discussed the Supreme Court’s “landmark decision in SAS, ruling that when the Patent Office institutes an Inter Partes Review, it must decide the patentability of all of the claims the petitioner has challenged.”
Email Williams & Connolly LLP Office
Please be aware that we cannot represent you until we have confirmed that doing so will not create a conflict of interests and we have agreed to the representation. Therefore, please do not send us any information about any matter until you receive a written statement from us that we have agreed to represent you (an “engagement letter”). Sending information to Williams & Connolly LLP will not create, and receipt does not constitute, an attorney-client relationship. Unless you have executed an engagement letter, Williams & Connolly’s receipt of information from you about a matter will not prevent the law firm from representing someone else who is adverse to you in the same matter, and any information that you provide may not be treated as privileged or confidential.
The best way for you to inquire regarding possible representation is to telephone one of our attorneys. Thank you for your interest in Williams & Connolly LLP.
Please click "Accept" to confirm that you agree to these terms.